TCL Archive Research teams link response to Iressa to mutations in EGF receptor. April 30, 2004Vol.30 No.18
TCL Archive Diet and Cancer Risk Explored In Studies Presented At AACR Annual Meeting April 30, 2004Vol.27 No.4
TCL Archive SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis. April 30, 2004Vol.30 No.18
TCL Archive Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer April 30, 2004Vol.27 No.4
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004Vol.30 No.18
TCL Archive Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs. April 30, 2004Vol.30 No.18
